Literature DB >> 9722470

First report of the isolation of high-level vancomycin-resistant Enterococcus faecium from a patient in Japan.

N Fujita, M Yoshimura, T Komori, K Tanimoto, Y Ike.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9722470      PMCID： PMC105893     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  12 in total

1.  Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria.

Authors:  S Dutka-Malen; R Leclercq; V Coutant; J Duval; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

2.  High-level plasmid-mediated gentamicin resistance and pheromone response of plasmids present in clinical isolates of Enterococcus faecalis.

Authors:  M Shiojima; H Tomita; K Tanimoto; S Fujimoto; Y Ike
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

3.  High incidence of hemolysin production by Enterococcus (Streptococcus) faecalis strains associated with human parenteral infections.

Authors:  Y Ike; H Hashimoto; D B Clewell
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

Review 4.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

5.  Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.

Authors:  R Leclercq; E Derlot; J Duval; P Courvalin
Journal:  N Engl J Med       Date:  1988-07-21       Impact factor: 91.245

6.  Study to determine the ability of clinical laboratories to detect antimicrobial-resistant Enterococcus spp. in Buenos Aires, Argentina.

Authors:  S T Cookson; H Lopardo; M Marin; R Arduino; M J Rial; M Altschuler; L Galanternik; J M Swenson; J I Tokars; W R Jarvis
Journal:  Diagn Microbiol Infect Dis       Date:  1997-10       Impact factor: 2.803

7.  High-level vancomycin-resistant enterococci causing hospital infections.

Authors:  A H Uttley; R C George; J Naidoo; N Woodford; A P Johnson; C H Collins; D Morrison; A J Gilfillan; L E Fitch; J Heptonstall
Journal:  Epidemiol Infect       Date:  1989-08       Impact factor: 2.451

8.  Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci.

Authors:  M Arthur; F Depardieu; P Reynolds; P Courvalin
Journal:  Mol Microbiol       Date:  1996-07       Impact factor: 3.501

9.  Major trends in the microbial etiology of nosocomial infection.

Authors:  D R Schaberg; D H Culver; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

10.  Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA.

Authors:  T D Bugg; G D Wright; S Dutka-Malen; M Arthur; P Courvalin; C T Walsh
Journal:  Biochemistry       Date:  1991-10-29       Impact factor: 3.162
View more
  11 in total

1.  Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci.

Authors:  R Kariyama; R Mitsuhata; J W Chow; D B Clewell; H Kumon
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

2.  Regional spread and control of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Kyoto, Japan.

Authors:  A Matsushima; S Takakura; M Yamamoto; Y Matsumura; M Shirano; M Nagao; Y Ito; Y Iinuma; T Shimizu; N Fujita; S Ichiyama
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-04       Impact factor: 3.267

3.  Vancomycin-resistant enterococci in humans and imported chickens in Japan.

Authors:  Yoshiyuki Ozawa; Koichi Tanimoto; Takahiro Nomura; Masao Yoshinaga; Yoshichika Arakawa; Yasuyoshi Ike
Journal:  Appl Environ Microbiol       Date:  2002-12       Impact factor: 4.792

4.  Mechanisms of resistance to imipenem and ampicillin in Enterococcus faecalis.

Authors:  Seiji Ono; Tetsuro Muratani; Tetsuro Matsumoto
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

5.  Structure-activity relationship of gelatinase biosynthesis-activating pheromone of Enterococcus faecalis.

Authors:  Kenzo Nishiguchi; Koji Nagata; Masaru Tanokura; Kenji Sonomoto; Jiro Nakayama
Journal:  J Bacteriol       Date:  2008-11-07       Impact factor: 3.490

6.  Trends in antimicrobial-drug resistance in Japan.

Authors:  Y Arakawa; Y Ike; M Nagasawa; N Shibata; Y Doi; K Shibayama; T Yagi; T Kurata
Journal:  Emerg Infect Dis       Date:  2000 Nov-Dec       Impact factor: 6.883

7.  Molecular characterization of vancomycin-resistant enterococcus faecium isolates from mainland China.

Authors:  Bo Zheng; Haruyoshi Tomita; Yong Hong Xiao; Shan Wang; Yun Li; Yasuyoshi Ike
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

8.  Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2201, encoding erythromycin resistance and cytolysin (Hly/Bac).

Authors:  Bo Zheng; Haruyoshi Tomita; Takako Inoue; Yasuyoshi Ike
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

9.  Dissemination and genetic analysis of the stealthy vanB gene clusters of Enterococcus faecium clinical isolates in Japan.

Authors:  Yusuke Hashimoto; Jun Kurushima; Takahiro Nomura; Koichi Tanimoto; Kiyoko Tamai; Hideji Yanagisawa; Komei Shirabe; Yasuyoshi Ike; Haruyoshi Tomita
Journal:  BMC Microbiol       Date:  2018-12-13       Impact factor: 3.605

10.  Identification and characterization of vancomycin-resistant Enterococcus species frequently isolated from laboratory mice.

Authors:  Hitoki Yamanaka; Toshikazu Takagi; Makiko Ohsawa; Naoto Yamamoto; Noriaki Kubo; Takahira Takemoto; Shoko Sasano; Ritsuko Masuyama; Kazutaka Ohsawa
Journal:  Exp Anim       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.